Fracture healing and drug therapies in osteoporosis

Amy Hoang-Kim, Letizia Gelsomini, Deianira Luciani, Antonio Moroni, Sandro Giannini

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Fracture repair has not been fully optimised and there is opportunity to increase the healing rate and reduce the number of complications using pharmacological means. While most anti-osteoporosis drugs have been widely tested for their ability to decrease the risk of osteoporotic fractures, fragility fractures still occur in patients under medical intervention. The primary purpose of this systematic review is to understand these underlying mechanisms between bone and drug therapies in osteoporosis and the overall promotion of fracture healing and callus formation. Databases such as MEDLINE, Google Scholar, EMBASE and CINAHL were searched and nine articles met all inclusion criteria. We report that there is still large controversy and a need for clinical trials to address the deficiencies found in animal models. There is no clear evidence yet as to whether complications during the course of healing are attributable to implant anchorage problems in osteoporotic bone or to possibly delayed healing in the aged.

Original languageEnglish
Pages (from-to)136-143
Number of pages8
JournalClinical Cases in Mineral and Bone Metabolism
Volume6
Issue number2
Publication statusPublished - May 2009

Fingerprint

Fracture Healing
Osteoporosis
Bone and Bones
Drug Therapy
Osteoporotic Fractures
Bony Callus
MEDLINE
Animal Models
Clinical Trials
Databases
Pharmacology
Pharmaceutical Preparations

Keywords

  • Callus formation
  • Drug therapies
  • Elderly
  • Fracture
  • Healng
  • Osteoporosis

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Hoang-Kim, A., Gelsomini, L., Luciani, D., Moroni, A., & Giannini, S. (2009). Fracture healing and drug therapies in osteoporosis. Clinical Cases in Mineral and Bone Metabolism, 6(2), 136-143.

Fracture healing and drug therapies in osteoporosis. / Hoang-Kim, Amy; Gelsomini, Letizia; Luciani, Deianira; Moroni, Antonio; Giannini, Sandro.

In: Clinical Cases in Mineral and Bone Metabolism, Vol. 6, No. 2, 05.2009, p. 136-143.

Research output: Contribution to journalArticle

Hoang-Kim, A, Gelsomini, L, Luciani, D, Moroni, A & Giannini, S 2009, 'Fracture healing and drug therapies in osteoporosis', Clinical Cases in Mineral and Bone Metabolism, vol. 6, no. 2, pp. 136-143.
Hoang-Kim A, Gelsomini L, Luciani D, Moroni A, Giannini S. Fracture healing and drug therapies in osteoporosis. Clinical Cases in Mineral and Bone Metabolism. 2009 May;6(2):136-143.
Hoang-Kim, Amy ; Gelsomini, Letizia ; Luciani, Deianira ; Moroni, Antonio ; Giannini, Sandro. / Fracture healing and drug therapies in osteoporosis. In: Clinical Cases in Mineral and Bone Metabolism. 2009 ; Vol. 6, No. 2. pp. 136-143.
@article{372746c8a7984c2591551c638ee0e25c,
title = "Fracture healing and drug therapies in osteoporosis",
abstract = "Fracture repair has not been fully optimised and there is opportunity to increase the healing rate and reduce the number of complications using pharmacological means. While most anti-osteoporosis drugs have been widely tested for their ability to decrease the risk of osteoporotic fractures, fragility fractures still occur in patients under medical intervention. The primary purpose of this systematic review is to understand these underlying mechanisms between bone and drug therapies in osteoporosis and the overall promotion of fracture healing and callus formation. Databases such as MEDLINE, Google Scholar, EMBASE and CINAHL were searched and nine articles met all inclusion criteria. We report that there is still large controversy and a need for clinical trials to address the deficiencies found in animal models. There is no clear evidence yet as to whether complications during the course of healing are attributable to implant anchorage problems in osteoporotic bone or to possibly delayed healing in the aged.",
keywords = "Callus formation, Drug therapies, Elderly, Fracture, Healng, Osteoporosis",
author = "Amy Hoang-Kim and Letizia Gelsomini and Deianira Luciani and Antonio Moroni and Sandro Giannini",
year = "2009",
month = "5",
language = "English",
volume = "6",
pages = "136--143",
journal = "Clinical Cases in Mineral and Bone Metabolism",
issn = "1724-8914",
publisher = "CIC Edizioni Internazionali s.r.l.",
number = "2",

}

TY - JOUR

T1 - Fracture healing and drug therapies in osteoporosis

AU - Hoang-Kim, Amy

AU - Gelsomini, Letizia

AU - Luciani, Deianira

AU - Moroni, Antonio

AU - Giannini, Sandro

PY - 2009/5

Y1 - 2009/5

N2 - Fracture repair has not been fully optimised and there is opportunity to increase the healing rate and reduce the number of complications using pharmacological means. While most anti-osteoporosis drugs have been widely tested for their ability to decrease the risk of osteoporotic fractures, fragility fractures still occur in patients under medical intervention. The primary purpose of this systematic review is to understand these underlying mechanisms between bone and drug therapies in osteoporosis and the overall promotion of fracture healing and callus formation. Databases such as MEDLINE, Google Scholar, EMBASE and CINAHL were searched and nine articles met all inclusion criteria. We report that there is still large controversy and a need for clinical trials to address the deficiencies found in animal models. There is no clear evidence yet as to whether complications during the course of healing are attributable to implant anchorage problems in osteoporotic bone or to possibly delayed healing in the aged.

AB - Fracture repair has not been fully optimised and there is opportunity to increase the healing rate and reduce the number of complications using pharmacological means. While most anti-osteoporosis drugs have been widely tested for their ability to decrease the risk of osteoporotic fractures, fragility fractures still occur in patients under medical intervention. The primary purpose of this systematic review is to understand these underlying mechanisms between bone and drug therapies in osteoporosis and the overall promotion of fracture healing and callus formation. Databases such as MEDLINE, Google Scholar, EMBASE and CINAHL were searched and nine articles met all inclusion criteria. We report that there is still large controversy and a need for clinical trials to address the deficiencies found in animal models. There is no clear evidence yet as to whether complications during the course of healing are attributable to implant anchorage problems in osteoporotic bone or to possibly delayed healing in the aged.

KW - Callus formation

KW - Drug therapies

KW - Elderly

KW - Fracture

KW - Healng

KW - Osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=76249089325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76249089325&partnerID=8YFLogxK

M3 - Article

C2 - 22461163

AN - SCOPUS:76249089325

VL - 6

SP - 136

EP - 143

JO - Clinical Cases in Mineral and Bone Metabolism

JF - Clinical Cases in Mineral and Bone Metabolism

SN - 1724-8914

IS - 2

ER -